The novel therapy of this peptide represents a significant breakthrough in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide088821.free-blogz.com/89637156/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment